Micronutrients and traumatic brain injury: a feasibility study
- Conditions
- Emotion dysregulationTraumatic Brain InjuryMental Health - AnxietyMental Health - DepressionMental Health - Other mental health disordersNeurological - Other neurological disordersInjuries and Accidents - Other injuries and accidents
- Registration Number
- ACTRN12619001216101
- Lead Sponsor
- niversity of Canterbury Foundation- donations given to the principal investigator
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
1) Between 6 and 13 years, 2) must be children or young people with a Traumatic Brain Injury more than a year old, and 3) meet the criteria for emotional dysregulation as defined by the Affective Reactivity Scale. Participants will be assessed on the ARI- P (parent scale). Those scoring more than 3 will be considered eligible.
1) A known allergy to any of the ingredient used in the intervention, 2) any known abnormality of mineral metabolism (e.g., Wilson's disease, haemochromatosis – assessed via blood tests), 3) ingestion of any medications with primarily central nervous system activity, including mood stabilizers, atomoxetine or stimulants. Participants must have been off their medications for a minimum of four weeks prior to the trial. Participants will not be encouraged to come off their medications in order to participate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Affective Reactivity Index (ARI) will be used to measure feelings, behaviours and impairment specific to irritability.[Baseline (week 0), baseline (week 2), once a month for the 6 months of the intervention, 6- months post intervention]
- Secondary Outcome Measures
Name Time Method